Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Weight loss injections are generally appropriate if: Your BMI is between 27-35 with obesity-related health conditions (or 30+ without) Youre committed to physician supervision and regular follow-ups You want to try a non-surgical option first You understand the medication is a long-term commitment, not a short course They may NOT be the right long-term fit if your BMI is over 35 with significant comorbidities, if youve already tried medications without reaching your target weight loss, experienced intolerable side effects, or find the ongoing cost unsustainable
Swissmedic approved Eli Lillys Mounjaro (tirzepatide) for type 2 diabetes in 2022 and for weight management in 2024
She is on the speakers bureau for Novo Nordisk, Eli Lilly and Company, Sanofi, Merck Sharp & Dohme, Boehringer Ingelheim, AstraZeneca and Janssen
Dehydration can also concentrate medications in the bloodstream, potentially intensifying side effects
Ivancic PC, Pearson AM, Tominaga Y, Simpson AK, Yue JJ, Panjabi MM
